Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis

Philip M Farrell1, Jannette Collins, Lynn S Broderick

  • 1Department of Pediatrics, University of Wisconsin, Madison, Wis, USA.

Radiology
|August 26, 2009
PubMed

Insights

Respiratory infection with mucoid Pseudomonas aeruginosa (PA) significantly correlates with bronchiectasis severity in children with cystic fibrosis. Early eradication of PA is crucial for preventing irreversible lung disease.

Area of Science:

  • Pediatric Pulmonology
  • Medical Microbiology
  • Radiology

Background:

  • Cystic fibrosis (CF) is a genetic disorder leading to chronic lung infections and progressive lung damage.
  • Bronchiectasis, an irreversible lung condition, is a common complication in children with CF.
  • Identifying risk factors for bronchiectasis is critical for timely intervention.

Purpose of the Study:

  • To investigate the correlation between bronchiectasis severity in pediatric CF patients and various clinical and microbiological factors.
  • To identify specific risk factors contributing to the development of irreversible lung disease in CF.

Main Methods:

  • A longitudinal epidemiologic evaluation was conducted on CF patients from a newborn screening trial (1985-2009).
  • Thin-section chest computed tomography (CT) was used to objectively assess bronchiectasis severity.
  • Respiratory secretions were cultured to differentiate mucoid and nonmucoid Pseudomonas aeruginosa (PA) infections.

Main Results:

  • Bronchiectasis was observed in 83% of the studied pediatric CF patients.
  • Respiratory infection with mucoid PA was the only significant risk factor correlated with bronchiectasis severity (P = .041).

Conclusions:

  • The severity of bronchiectasis in children with CF is significantly associated with mucoid PA respiratory infections.
  • Preventive strategies should focus on minimizing exposure to and ensuring early eradication of PA in CF patients.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...